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 Is Inflammatory Bowel Disease More 
Severe when It Appears at Younger Ages? 
 Gerhard Rogler 
 Departement für Innere Medizin, Klinik für Gastroenterologie und Hepatologie, Universitätsspital Zürich,
 Zürich , Schweiz 
tory is complicated by the fact that treatment options 
have changed dramatically during the last 10 years. 
Therefore, most of the historic cohort data are only of 
limited value today. A more recent study from a larger 
North American registry demonstrated that at onset of 
UC, about 80% of pediatric patients had pancolitis, 80% 
had moderate to severe colitis, and 80% received cortico-
steroids within 30 days of diagnosis. A steroid-dependent 
disease course was found in 45% at 1 year, which is clear-
ly higher compared with adult patients  [5] . The increased 
severity of disease in this population is further illustrated 
by the fact that 5% of those patients had to undergo col-
ectomy within a year of diagnosis. Levine  [6]  subsequent-
ly concluded that pediatric UC not only presents with 
more extensive disease, but also with more severe and re-
fractory disease. It is obvious that this has a negative in-
fluence on the quality of life  [7] .
 The data of Lee et al. [1] further support a more severe 
disease course of UC at younger ages. They performed a 
retrospective study on 455 patients with UC who were 
diagnosed and treated between 1990 and 2008 at a single 
tertiary institution in Korea. They divided the patients 
into two groups: one older and one younger than 40 years 
at diagnosis. Disease severity, frequency of pancolitis, 
and steroid use rate were found to be higher in the young 
patients. In contrast to the findings of the pediatric co-
 In this issue of  Digestion , Lee and coworkers try to an-
swer the important question whether patients with ulcer-
ative colitis (UC) diagnosed at a young age have more 
severe disease activity than patients diagnosed when old-
er  [1] . Similar to the situation in older inflammatory bow-
el disease patients, disease behavior varies dramatically 
among children, adolescents and younger patients. There-
fore, conflicting data have been published. However, re-
cent evidence suggests that at least in the case of pediatric 
onset of UC the disease may present differently and show 
a different behavior as compared to onset of disease at 
older ages. 
 UC usually is diagnosed in late adolescence and early 
adulthood. However, also older patients are not rare as 
the number of total cases increased in recent years. Epi-
demiological studies have shown that in 40–50% of adult 
patients with UC, inflammation is restricted to the rec-
tum or sigmoid colon. In contrast, 25–35% of patients 
have extended disease or pancolitis  [2, 3] . With respect to 
this, pediatric UC has been shown to behave clearly dif-
ferent. Approximately 60–70% of patients with pediatric 
onset of UC present with pancolitis, as opposed to ap-
proximately 20–30% in adults  [4, 5] . In pediatric patients, 
proctitis is a very unusual manifestation of the disease. 
 Data on the natural history of UC in different age 
groups are scarce. The interpretation of the natural his-
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hort, surgery rates were not significantly different be-
tween the two groups. This indicates one of the limita-
tions of the study: Similar to what has been discussed in 
Crohn’s disease with respect to the Vienna classification 
(and now has resulted in the Montréal classification), the 
discrimination between patients older or younger than 
40 years is too crude  [8] . In the Montreal classification for 
Crohn’s disease, the age group younger than 40 years was 
split into two groups: A1 below 16 years and A2 between 
17 and 40 years. The third group is the age group above 
40 years  [8] . It is important to use similar age groups in 
future analyses to learn more about age-related disease 
behavior of UC. This can help understand the specific 
needs of each age group and improve age-specific treat-
ment.
 
 References 
 1 Lee JH, Cheon JH, Moon CM, Park JJ, Hong 
SP, Kim TI, Kim WH: Do patients with ul-
cerative colitis diagnosed at a young age have 
more severe disease activity than patients di-
agnosed when older? Digestion 2010;81:237–
243. 
 2 Henriksen M, Jahnsen J, Lygren I, Sauar J, 
Kjellevold O, Schulz T, et al: Ulcerative coli-
tis and clinical course: results of a 5-year 
population-based follow-up study (the IB-
SEN study). Inflamm Bowel Dis 2006; 12: 
 543–550. 
 3 Henriksen M, Jahnsen J, Lygren I, Sauar J, 
Schulz T, Stray N, et al: Change of diagnosis 
during the first five years after onset of in-
flammatory bowel disease: results of a pro-
spective follow-up study (the IBSEN Study). 
Scand J Gastroenterol 2006; 41: 1037–1043. 
 4 Heyman MB, Kirschner BS, Gold BD, Ferry 
G, Baldassano R, Cohen SA, et al: Children 
with early-onset inflammatory bowel dis-
ease (IBD): analysis of a pediatric IBD con-
sortium registry. J Pediatr 2005; 146: 35–40. 
 5 Hyams J, Markowitz J, Lerer T, Griffiths A, 
Mack D, Bousvaros A, et al: The natural his-
tory of corticosteroid therapy for ulcerative 
colitis in children. Clin Gastroenterol Hepa-
tol 2006; 4: 1118–1123. 
 6 Levine A: Pediatric inflammatory bowel dis-
ease: is it different? Dig Dis 2009; 27: 212–
214. 
 7 Greth J, Torok HP, Koenig A, Folwaczny C: 
Comparison of inflammatory bowel disease 
at younger and older age. Eur J Med Res 
2004; 9: 552–554. 
 8 Satsangi J, Silverberg MS, Vermeire S, Co-
lombel JF: The Montreal classification of in-
flammatory bowel disease: controversies, 
consensus, and implications. Gut 2006; 55: 
 749–753. 
 
